LivsMed, 2305 Historic Decatur Road, Suite 100, San Diego, CA (2026)

12/11/2025

In 2025, LivsMed continued advancing surgical innovation by bringing robotic capability to operating rooms in hospitals and ASCs across the country. We also remained committed to our mission of democratizing healthcare — ensuring that every breakthrough we deliver isn’t just innovative, but truly affordable. LivsMed’s new double-jointed, fully articulating Clip Applier delivers the widest range of motion available, even in the narrow pelvic space. Surgical teams and patients are now able to benefit from more precise angles of approach and flexible movements that better target critical structures and achieve secure clip application.

12/09/2025

In 2025, LivsMed continued advancing surgical innovation by bringing robotic capability to operating rooms in hospitals and ASCs across the country. We also remained committed to our mission of democratizing healthcare — ensuring that every breakthrough we deliver isn’t just innovative, but truly affordable. The telesurgery capabilities of LivsMed’s new STARK™ RAS were demonstrated in an early feasibility wet lab study on July 1st. Conducted in conjunction with Sovato, this study demonstrated the viability of long-distance telesurgery using the STARK platform. Live procedures were performed with the surgeon console in Santa Barbara, CA, and the STARK robot in Chicago, IL.

Read the full story here.
https://livsmed.us/livsmed-unveils-new-robotic-system-with-telesurgery-capabilities-partners-with-sovato-for-remote-enabling-technology/

LivsMed’s STARK™ RAS system is not approved for use and not for sale.

12/04/2025

In 2025, LivsMed continued advancing surgical innovation by bringing robotic capability to operating rooms in hospitals and ASCs across the country. We also remained committed to our mission of democratizing healthcare — ensuring that every breakthrough we deliver isn’t just innovative, but truly affordable. With the approval of our 5mm Hook and Spatula, surgeons were given reliable monopolar coagulation and dissection capabilities, enabling them to approach the target area from any angle with a full range of motion for even complex maneuvers. LivsMed instruments bring articulation to any O.R., anytime. They can also enhance your robotic procedures, promoting efficiency and cost savings.

12/02/2025

In 2025, LivsMed continued advancing surgical innovation by bringing robotic capability to operating rooms in hospitals and ASCs across the country. We also remained committed to our mission of democratizing healthcare — ensuring that every breakthrough we deliver isn’t just innovative, but truly affordable. With ArtiSeal, the world’s 1st and only 90° Articulating Double-Jointed Vessel Sealer, LivsMed brought the benefits of perpendicular sealing and true articulation to every Hospital and ASC.

www.livsmed.us/videos

11/26/2025

It has certainly been an exciting year at LivsMed with so many new products! We have a lot to be thankful for but what we are most thankful for is the surgical teams who advance patient care every day and inspire our own innovation. Thank You! And Happy Thanksgiving.

11/21/2025

LivsMed is working to democratize advanced remote robotic surgery — making it not only accessible, but also affordable for hospitals and patients worldwide.
Today, Dr. Max Hazeltine of City of Hope presented the study results to CRSA attendees from the recent wet-lab study, where LivsMed demonstrated its STARK™ telesurgery-native robotic system. The STARK robotic console in Santa Barbara, CA was connected to the Robot in Chicago, IL via the Sovato network. The results confirmed the feasibility and safety of complex remote surgical procedures using the STARK system with Sovato’s telecommunications platform.
To learn more, email infoUSA@LivsMed.com.

STARK™ is not approved for use and not for sale.

11/18/2025

If you’re wondering where the latest high-tech innovations in laparoscopic surgery are coming from, take a look at LivsMed.
LivsMed and Sovato recently completed an early-feasibility wet-lab study—spanning more than 2,000 miles—using STARK, the world’s newest telesurgery-native robot. Visitors can learn more at the 16th Clinical Robotic Surgery Association (CRSA) World Congress in Huntington Beach, as we wrap up our November High-Tech MedTech Roadshow.
So far, the Roadshow has made stops at the 50th Annual Korean-American Medical Association (K**A) Scientific Convention in Washington, D.C., the AAGL25 Global Conference in Vancouver, and the ASMBS Weekend Meeting in Louisville, KY. Attendees have experienced the ArtiSential™ line—now featuring more than 50 fully articulating instruments and end effectors; the ArtiSential 5 series, the first 5mm articulating laparoscopic line offering enhanced flexibility and ease of use; the ArtiSential Clip Applier, the only 90° double-jointed articulating clip applier; and ArtiSeal™, the only 90° double-jointed articulating vessel sealer.
If you can’t see us on the road, email infoUSA@LivsMed.com to schedule a meeting with your local LivsMed representative and experience LivsMed’s solutions at work in your hospital or ASC.
STARK™ is not approved for use and not for sale.

11/14/2025

If you’re wondering where the latest high-tech innovations in laparoscopic surgery are coming from, take a look at LivsMed.
Our ArtiSential™ line now features more than 50 fully articulating instruments and end effectors. The ArtiSential 5 series—the first 5mm articulating laparoscopic line—offers enhanced flexibility and ease of use. Then there’s the ArtiSential Clip Applier, the only 90° double-jointed articulating clip applier. Add to that ArtiSeal™, the only 90° double-jointed articulating vessel sealer.
If that’s not enough, we recently completed an early-feasibility wet-lab study—spanning 2,000 miles—with STARK, the world’s newest telesurgery-native robot.
Want to learn more? We’re continuing our high-tech MedTech Roadshow! We’ve already appeared at the 50th Annual Korean-American Medical Association (K**A) Scientific Convention in Washington, D.C., and the AAGL25 Global Conference in Vancouver. Now, we’re in Louisville for the ASMBS Weekend Meeting. Then we’ll be wrapping up November at the 16th Clinical Robotic Surgery Association (CRSA) World Congress in Huntington Beach.
If you can’t see us on the road, email infoUSA@LivsMed.com to schedule a meeting with your local LivsMed representative and experience LivsMed’s solutions at work in your hospital or ASC.

STARK™ is not approved for use and not for sale.

11/11/2025

Stop by Booth 537 for your hands-on opportunity with ArtiSential™ and explore the ArtiSeal™ vessel sealer.
Also, don’t miss Dr. Yufan Brandon Chen’s presentation on suturing efficiency with the ArtiSential™ Needle Driver — Tuesday, November 11, during Oral Session 05 from 11:00 AM to 12:00 PM
*ArtiSeal is not yet indicated for GYN by FDA

11/10/2025

Visit us at Booth 537!
Experience ArtiSential™ with 90° articulation and tactile control, and see the ArtiSeal™ vessel sealer in action.

11/07/2025

As LivsMed’s High-Tech MedTech Roadshow continues, we’ve wrapped up our visit to the 50th Annual Korean-American Medical Association (K**A) Scientific Convention in Washington, D.C. Next stop: the AAGL25 Global Congress in Vancouver, followed by the ASMBS Weekend Meeting in Louisville and the 16th Clinical Robotic Surgery Association (CRSA) World Congress in Huntington Beach.

Join us in Vancouver for a hands-on opportunity with the ArtiSential™ line, including our newest additions — the ArtiSential 5mm Hook and 5mm Spatula.

While you’re at the conference, be sure to attend Dr. Yufan Brandon Chen’s presentation: “Conventional Laparoscopic vs. Multi-Degree of Freedom Articulating Instruments in Minimally Invasive Surgical Suturing.” The study, which confirms the efficiency and time-saving advantages of suturing with the ArtiSential Needle Driver, will be presented Tuesday, November 11th, during Oral Session 05, from 11:00 AM to 12:00 PM.

Dr. Chen serves as Chief, Division of Urogynecology and Pelvic Reconstructive Surgery at Kern Medical, Assistant Professor at the David Geffen School of Medicine at UCLA, and Associate Program Director, OBGYN Residency Program.

Can’t meet us on the road? Email infoUSA@LivsMed.com to schedule a meeting with your local LivsMed representative and experience LivsMed’s innovative solutions in your hospital or ASC.

11/05/2025

On Tuesday, November 11, Yufan “Brandon” Chen, MD, FACOG, will present the findings of his study, “Conventional Laparoscopic vs. Multi-Degree of Freedom Articulating Instruments in Minimally Invasive Surgical Suturing.”

The study evaluated the ArtiSential™ laparoscopic needle driver—a novel, multi-degree-of-freedom instrument—and compared its performance to conventional (straight stick) laparoscopic instruments. Specifically, it examined knot-tying times during laparoscopic sacrocolpopexy procedures.

Dr. Chen’s presentation will take place during Oral Session 05, from 11:00 AM to 12:00 PM at the Vancouver Convention Centre, Vancouver, B.C., Canada.
Dr. Chen serves as Chief, Division of Urogynecology and Pelvic Reconstructive Surgery, Kern Medical; Assistant Professor, David Geffen School of Medicine at UCLA and Associate Program Director, OBGYN Residency Program.

If you’re unable to attend Dr. Chen’s presentation or visit LivsMed at AAGL Booth #537, please email infoUSA@LivsMed.com to schedule a meeting with your local LivsMed representative and experience LivsMed’s innovations in action at your hospital or ASC.

LivsMed

12/11/2025

12/09/2025

12/04/2025

12/02/2025

11/26/2025

11/21/2025

11/18/2025

11/14/2025

11/11/2025

11/10/2025

11/07/2025

11/05/2025

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category

Company Overview